Catherine Hankins

Amsterdam Institute for Global Health and Development

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial”.

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial

BMJ Open(2023)10.1136/bmjopen-2023-076843

N/A

0.104DataRank · unranked

1 citations

Nigel Garrett, Disebo Potloane, Izukanji Sikazwe, Edmund V. Capparelli, Ishana Harkoo +22 more

Decreased Time to Viral Suppression After Implementation of Targeted Testing and Immediate Initiation of Treatment of Acute Human Immunodeficiency Virus Infection Among Men Who Have Sex With Men in Amsterdam

Clinical Infectious Diseases(2020)10.1093/cid/ciaa505

N/A

0DataRank · unranked

30 citations

Martijn S. van Rooijen, M Hillebregt, Ard van Sighem, Colette Smit, Arjan Hogewoning +85 more